Figurska M, Robaszkiewicz J, Wierzbowska J. Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis. Klinika Oczna / Acta Ophthalmologica Polonica. 2010;112(2):147-150.
APA
Figurska, M., Robaszkiewicz, J., & Wierzbowska, J. (2010). Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis. Klinika Oczna / Acta Ophthalmologica Polonica, 112(2), 147-150.
Chicago
Figurska, Małgorzata, Jacek Robaszkiewicz, and Joanna Wierzbowska. 2010. "Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis". Klinika Oczna / Acta Ophthalmologica Polonica 112 (2): 147-150.
Harvard
Figurska, M., Robaszkiewicz, J., and Wierzbowska, J. (2010). Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis. Klinika Oczna / Acta Ophthalmologica Polonica, 112(2), pp.147-150.
MLA
Figurska, Małgorzata et al. "Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 112, no. 2, 2010, pp. 147-150.
Vancouver
Figurska M, Robaszkiewicz J, Wierzbowska J. Safety of ranibizumab therapy in wet AMD
and the role of vascular endothelial growth
factors in physiological angiogenesis. Klinika Oczna / Acta Ophthalmologica Polonica. 2010;112(2):147-150.
